| 52442 | In this add–on procedure, the provider uses a cystourethroscope to place an additional permanent adjustable transprostatic implant to retract prostatic lobes that obstruct the urethra. | 270 | $980 | $259.2K |
| 52441 | Using a cystourethroscope, the provider places a single permanent adjustable transprostatic implant to retract prostatic lobes that obstruct the urethra. | 50 | $1,380 | $69.2K |
| J3490 | Unclassified drugs | 650 | $90 | $56.1K |
| 55874 | Under imaging guidance, the provider inserts a needle through the perineum, the area between the anus and the scrotum, and injects one or more biodegradable materials, i.e., material that decomposes… | 20 | $3,240 | $48.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 380 | $110 | $41.9K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 170 | $240 | $39.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 450 | $80 | $34.3K |
| 53854 | The provider uses a radiofrequency–generated water vapor thermal device to destroy prostate tissue to treat BPH and lower urinary tract symptoms. | 20 | $1,830 | $31K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 170 | $140 | $23K |
| 52224 | The provider inspects the urethra, prostatic urethra (in men), the interior of the bladder, and ureteric openings using a cystoscope passed through the urethra and into the bladder; he destroys… | 30 | $840 | $21.8K |